Gastric cancer cells over-expressing Polβ (common trait in stomach tumors) present increased resistance to 6-TG and also to MMS upon inhibition of MGMT by O6-BzGua (that is in clinical trials). This evidence concerns the gene MGMT and gastric cancer.